CLINICAL_TRIALS
trial_result
· 2018-03-27
Clinical Trial Update: Preventing Alcohol Withdrawal Syndrome With Oral Baclofen [Phase 3]
Summary
Phase 3 clinical trial evaluating oral baclofen to prevent alcohol withdrawal syndrome was terminated; results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Denver Health and Hospital Authority | Conditions: Alcohol Withdrawal Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2018-03-27